Advertisement
  • Loading metrics

Soluble Rhesus Lymphocryptovirus gp350 Protects against Infection and Reduces Viral Loads in Animals that Become Infected with Virus after Challenge

  • Junji Sashihara,

    Current address: Department of Pediatrics, Kansai Rousai Hospital, Hyogo, Japan.

    Affiliation Medical Virology Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

  • Yo Hoshino,

    Current address: Astellas Pharma Inc., Tokyo, Japan.

    Affiliation Medical Virology Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

  • J. Jason Bowman,

    Affiliation Medical Virology Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

  • Tammy Krogmann,

    Affiliation Medical Virology Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

  • Peter D. Burbelo,

    Affiliation Neurobiology and Pain Therapeutics Section, Laboratory of Sensory Biology, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, United States of America

  • V. McNeil Coffield,

    Current address: Department of Biology, High Point University, High Point, North Carolina, United States of America.

    Affiliation AlphaVax, Inc., Research Triangle Park, North Carolina, United States of America

  • Kurt Kamrud,

    Current address: Harrisvaccines, Inc. Ames, Iowa, United States of America.

    Affiliation AlphaVax, Inc., Research Triangle Park, North Carolina, United States of America

  • Jeffrey I. Cohen

    jcohen@niaid.nih.gov

    Affiliation Medical Virology Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

Soluble Rhesus Lymphocryptovirus gp350 Protects against Infection and Reduces Viral Loads in Animals that Become Infected with Virus after Challenge

  • Junji Sashihara, 
  • Yo Hoshino, 
  • J. Jason Bowman, 
  • Tammy Krogmann, 
  • Peter D. Burbelo, 
  • V. McNeil Coffield, 
  • Kurt Kamrud, 
  • Jeffrey I. Cohen
PLOS
x

Viewed info

Cited info

Saved info

Discussed info

Questions or concerns about usage data? Please let us know.